Chromadex Corp Stock Analysis
| CDXC Stock | USD 7.72 0.08 1.05% |
Chromadex Corp is overvalued with Real Value of 6.52 and Target Price of 5.17. The main objective of Chromadex Corp stock analysis is to determine its intrinsic value, which is an estimate of what Chromadex Corp is worth, separate from its market price. There are two main types of Chromadex Corp's stock analysis: fundamental analysis and technical analysis.
The Chromadex Corp stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Chromadex Corp's ongoing operational relationships across important fundamental and technical indicators.
Chromadex |
Chromadex Stock Analysis Notes
About 35.0% of the company shares are held by company insiders. The company had not issued any dividends in recent years. Chromadex Corp had 1:3 split on the 13th of April 2016. ChromaDex Corporation operates as a bioscience company focusing on healthy aging. ChromaDex Corporation is headquartered in Los Angeles, California. Chromadex Corp operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 115 people. For more info on Chromadex Corp please contact Frank Jaksch at 310 388 6706 or go to https://www.chromadex.com.Chromadex Corp Quarterly Total Revenue |
|
Chromadex Corp Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Chromadex Corp's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Chromadex Corp or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| Chromadex Corp is way too risky over 90 days horizon | |
| Chromadex Corp appears to be risky and price may revert if volatility continues | |
| The company reported the previous year's revenue of 83.57 M. Net Loss for the year was (4.94 M) with profit before overhead, payroll, taxes, and interest of 42.8 M. | |
| Chromadex Corp has a poor financial position based on the latest SEC disclosures | |
| About 35.0% of the company shares are held by company insiders | |
| Latest headline from MacroaxisInsider: Disposition of 82734 shares by Lee Jeong James of Chromadex Corp at 1.52 subject to Rule 16b-3 |
Chromadex Corp Upcoming and Recent Events
Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Chromadex Corp previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 13th of March 2024 Upcoming Quarterly Report | View | |
| 8th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 13th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Chromadex Largest EPS Surprises
Earnings surprises can significantly impact Chromadex Corp's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2024-10-31 | 2024-09-30 | 0.01 | 0.02 | 0.01 | 100 | ||
2024-05-08 | 2024-03-31 | -0.02 | -0.01 | 0.01 | 50 | ||
2023-08-09 | 2023-06-30 | -0.04 | -0.03 | 0.01 | 25 |
Chromadex Corp Environmental, Social, and Governance (ESG) Scores
Chromadex Corp's ESG score is a quantitative measure that evaluates Chromadex Corp's performance and commitment regarding environmental, social, and governance (ESG) factors. These scores are becoming increasingly crucial in investment decision-making processes, providing insights into non-financial aspects of Chromadex Corp's operations that may have significant financial implications and affect Chromadex Corp's stock price as well as guide investors towards more socially responsible investments.
Chromadex Stock Institutional Investors
| Shares | Millennium Management Llc | 2024-06-30 | 192.3 K | Bank Of New York Mellon Corp | 2024-06-30 | 190.4 K | Winton Capital Group Ltd | 2024-09-30 | 178.1 K | Connor Clark & Lunn Inv Mgmt Ltd | 2024-06-30 | 158.1 K | Gamco Investors, Inc. Et Al | 2024-09-30 | 143.2 K | Charles Schwab Investment Management Inc | 2024-09-30 | 140.2 K | Ubs Group Ag | 2024-06-30 | 139.7 K | Morgan Stanley - Brokerage Accounts | 2024-06-30 | 139.5 K | Strs Ohio | 2024-09-30 | 104.1 K | Vanguard Group Inc | 2024-09-30 | 3.4 M | Blackrock Inc | 2024-06-30 | 3.1 M |
Chromadex Market Capitalization
The company currently falls under 'Small-Cap' category with a current market capitalization of 589.68 M.Chromadex Profitablity
The company has Profit Margin (PM) of 0.02 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.06 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.06.| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.09) | (0.10) | |
| Return On Capital Employed | (0.16) | (0.17) | |
| Return On Assets | (0.09) | (0.09) | |
| Return On Equity | (0.17) | (0.18) |
Management Efficiency
As of November 30, 2024, Return On Tangible Assets is expected to decline to -0.1. In addition to that, Return On Capital Employed is expected to decline to -0.17. At present, Chromadex Corp's Intangible Assets are projected to increase significantly based on the last few years of reporting. The current year's Other Current Assets is expected to grow to about 2.6 M, whereas Total Assets are forecasted to decline to about 28.4 M. Chromadex Corp's management efficiency ratios could be used to measure how well Chromadex Corp manages its routine affairs as well as how well it operates its assets and liabilities.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 0.38 | 0.24 | |
| Tangible Book Value Per Share | 0.37 | 0.23 | |
| Enterprise Value Over EBITDA | (21.36) | (22.43) | |
| Price Book Value Ratio | 3.77 | 3.58 | |
| Enterprise Value Multiple | (21.36) | (22.43) | |
| Price Fair Value | 3.77 | 3.58 | |
| Enterprise Value | 205.9 M | 216.2 M |
The management strategies employed by Chromadex Corp's are designed to enhance shareholder value and ensure long-term growth. We assess the effectiveness of these strategies in our stock analysis.
Operating Margin 0.0626 | Profit Margin 0.0162 | Beta 1.88 | Return On Assets 0.0051 | Return On Equity 0.0482 |
Technical Drivers
As of the 30th of November, Chromadex Corp shows the Mean Deviation of 3.91, downside deviation of 2.7, and Risk Adjusted Performance of 0.1415. Chromadex Corp technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.Chromadex Corp Price Movement Analysis
The output start index for this execution was nine with a total number of output elements of fifty-two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Chromadex Corp middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Chromadex Corp. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Chromadex Corp Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Chromadex Corp insiders, such as employees or executives, is commonly permitted as long as it does not rely on Chromadex Corp's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Chromadex Corp insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Chromadex Corp Outstanding Bonds
Chromadex Corp issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Chromadex Corp uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Chromadex bonds can be classified according to their maturity, which is the date when Chromadex Corp has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Volcan Compania Minera Corp BondUSP98047AC08 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| CHRISTUS HEALTH 4341 Corp BondUS17108JAA16 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MPLX LP 4875 Corp BondUS55336VAG59 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View |
Chromadex Corp Predictive Daily Indicators
Chromadex Corp intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Chromadex Corp stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Chromadex Corp Corporate Filings
F4 | 25th of November 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
8K | 21st of November 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
F3 | 8th of November 2024 The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock | ViewVerify |
10Q | 31st of October 2024 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations | ViewVerify |
F3 | 23rd of October 2024 The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock | ViewVerify |
8K | 11th of October 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
8K | 20th of September 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
F4 | 26th of August 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
Chromadex Corp Forecast Models
Chromadex Corp's time-series forecasting models are one of many Chromadex Corp's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Chromadex Corp's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Chromadex Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Chromadex Corp prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Chromadex shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Chromadex Corp. By using and applying Chromadex Stock analysis, traders can create a robust methodology for identifying Chromadex entry and exit points for their positions.
| Last Reported | Projected for Next Year | ||
| Pretax Profit Margin | (0.06) | (0.06) | |
| Operating Profit Margin | (0.07) | (0.07) | |
| Net Loss | (0.06) | (0.06) | |
| Gross Profit Margin | 0.61 | 0.35 |
Current Chromadex Analysis - Recommendations
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Chromadex analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Chromadex analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
| Target Price | Advice | # of Analysts | |
| 5.17 | Strong Buy | 5 | Odds |
Most Chromadex analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Chromadex stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Chromadex Corp, talking to its executives and customers, or listening to Chromadex conference calls.
Chromadex Stock Analysis Indicators
Chromadex Corp stock analysis indicators help investors evaluate how Chromadex Corp stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Chromadex Corp shares will generate the highest return on investment. By understating and applying Chromadex Corp stock analysis, traders can identify Chromadex Corp position entry and exit signals to maximize returns.
| Begin Period Cash Flow | 20.4 M | |
| Common Stock Shares Outstanding | 75 M | |
| Total Stockholder Equity | 28.5 M | |
| Property Plant And Equipment Net | 4.5 M | |
| Cash And Short Term Investments | 27.3 M | |
| Cash | 27.3 M | |
| Accounts Payable | 10.2 M | |
| Net Debt | -23.9 M | |
| 50 Day M A | 4.8562 | |
| Total Current Liabilities | 20.6 M | |
| Other Operating Expenses | 89.2 M | |
| Non Current Assets Total | 5.4 M | |
| Forward Price Earnings | 58.8235 | |
| Non Currrent Assets Other | 383 K | |
| Stock Based Compensation | 4.8 M |
Complementary Tools for Chromadex Stock analysis
When running Chromadex Corp's price analysis, check to measure Chromadex Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chromadex Corp is operating at the current time. Most of Chromadex Corp's value examination focuses on studying past and present price action to predict the probability of Chromadex Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Chromadex Corp's price. Additionally, you may evaluate how the addition of Chromadex Corp to your portfolios can decrease your overall portfolio volatility.
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |